Association of an MHC class II haplotype with increased risk of polymyositis in Hungarian Vizsla dogs.
Association of an MHC class II haplotype with increased risk of polymyositis in Hungarian Vizsla dogs.
复制标题
DOI:
10.1371/journal.pone.0056490
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Kennedy LJ
中科院分区:
文献类型:
--
作者:
Massey J;Rothwell S;Rusbridge C;Tauro A;Addicott D;Chinoy H;Cooper RG;Ollier WE;Kennedy LJ
A breed-specific polymyositis is frequently observed in the Hungarian Vizsla. Beneficial clinical response to immunosuppressive therapies has been demonstrated which points to an immune-mediated aetiology. Canine inflammatory myopathies share clinical and histological similarities with the human immune-mediated myopathies. As MHC class II associations have been reported in the human conditions we investigated whether an MHC class II association was present in the canine myopathy seen in this breed. 212 Hungarian Vizsla pedigree dogs were stratified both on disease status and degree of relatedness to an affected dog. This generated a group of 29 cases and 183 “graded” controls: 93 unaffected dogs with a first degree affected relative, 44 unaffected dogs with a second degree affected relative, and 46 unaffected dogs with no known affected relatives. Eleven DLA class II haplotypes were identified, of which, DLA-DRB1*02001/DQA1*00401/DQB1*01303, was at significantly raised frequency in cases compared to controls (OR = 1.92, p = 0.032). When only control dogs with no family history of the disease were compared to cases, the association was further strengthened (OR = 4.08, p = 0.00011). Additionally, a single copy of the risk haplotype was sufficient to increase disease risk, with the risk substantially increasing for homozygotes. There was a trend of increasing frequency of this haplotype with degree of relatedness, indicating low disease penetrance. These findings support the hypothesis of an immune-mediated aetiology for this canine myopathy and give credibility to potentially using the Hungarian Vizsla as a genetic model for comparative studies with human myositis.
登录
查看更多内容
影响因子:
9.8
作者:
Barcellos, LF;Oksenberg, JR;Hauser, SL
通讯作者:
Hauser, SL
影响因子:
1.8
作者:
Shelton, G. Diane;Hoffman, Eric P.;Nagaraju, Kanneboyina
通讯作者:
Nagaraju, Kanneboyina
影响因子:
--
作者:
Greer, K. A.;Wong, A. K.;Neff, M. W.
通讯作者:
Neff, M. W.
影响因子:
1.4
作者:
Clark, LA;Credille, KM;Rees, CA
通讯作者:
Rees, CA
影响因子:
1.8
作者:
Hankel, Sabine;Shelton, G. Diane;Engvall, Eva
通讯作者:
Engvall, Eva